About BiosparQ

BiosparQ B.V. is a privately-held in vitro diagnostics company dedicated to provide healthcare professionals with a unique solution for rapid diagnostics of infectious diseases that improves patient outcomes, lowers healthcare costs and helps turn back Antimicrobial Resistance (AMR).

BiosparQ has focused its efforts on research into and the development of the Cirrus D20 medical diagnostic platform, based on proprietary DigiTOF® technology. This technology enables direct analysis of patient samples using a Single-cell MALDI-TOF approach. DigiTOF® was initially developed by the TU Delft (Prof. J. Marijnissen et.al.) in co-operation with the Dutch Contract Research Organization TNO, under contracts of the US and Dutch Ministries of Defense in the early 2000s.

After incorporation and closing of seed funding rounds in 2009, BiosparQ began as a virtual company based in Delft. In 2012, a substantial series A round was closed, which enabled BiosparQ to grow into a fully integrated company.  All DigiTOF® assets from TU Delft / TNO was acquired (Patent portfolio and Cirrus D20 prototype hard- and software). It was decided move to the Leiden Bioscience Park, renting well equipped laboratories and offices from Biopartner foundation.

In 2016 a series B funding round was closed and in 2018 the company was granted an Innovation Credit by the Dutch government, enabling the company to mature the Cirrus D20 platform and develop, validate and certify the first applications.

Since 2009, the BiosparQ established an international network of clinical partners that support the company to create the applications pipeline. Several (inter)national subsidies were granted to the BiosparQ and its partners. In 2018, a supply chain consisting of high-tech suppliers was created to prepare for production qualification.

Contact

BiosparQ B.V.
Galileïweg 8
NL-2333 BD Leiden
The Netherlands

info@biosparq.nl

https://www.biosparq.nl

News items

The 2020 Techmed Event: The Congress

SHARING EXPERTISE, EXPERIENCE AND IDEAS FOR THE FUTURE
In…

Pre-session: Launch of the Organ On Chip Centre Twente

The new Organ-on-Chip Center Twente is a center of expertise…

Virtuele editie CES 2021: ‘Tech Solutions for Global Challenges’

Heeft u een technologische innovatieve oplossing voor een wereldwijde…

Virtual COMPAMED 2020 digital fair participation “High-tech for Medical Devices”

COMPAMED 2020 and MEDICA 2020, the world-leading information…

Webinar Export en betaling: Letter of Credit voor beginners

Exporteer je en heb je onzekerheid over de betaling? Misschien…

Holland High Tech Najaarsevenement

VEERKRACHT
Een sterke HighTech werkt voor Nederland!
Het Holland…

Professional video offer for iMNC2020 exhibitors

The exhibitors have started to build their exhibitor booth for…
1 oktober 2020/door Aurélie Veltema

Call for your input: Smart industry project NanoBio

The NanoBio research group is involved in many different application-…
25 september 2020/door Aurélie Veltema

First pre-event iMNC2020 on public-private collaboration very successful – Up next the Nano4Agri/Food event

On September 23, the iMNC2020 hosted the first pre-meeting for…
25 september 2020/door Aurélie Veltema

Nanotechnology roadmap update October 2020

At the end of 2019, the vision for Nanotechnology into the future…
15 september 2020/door Aurélie Veltema

Information Meeting Mission-driven call Key Technologies (KIC)

Key Technologies are technologies of the "future" that will have…

iMNC2020 pre-meeting on public private collaboration in times of pandemic

Public Private Collaborations – Lessons learnt in times of…